PCE Home Study
Managing the Spectrum of Psoriatic Disease in Primary Care
Release Date: August 31, 2020
Expiration Date: August 30, 2021
CE/CME Credit Hours: 1.50
Pharmacology Credit Hours: 1.50
Begin »
program overview
Program Description
Psoriatic disease, comprising psoriasis and psoriatic arthritis, is a chronic, systemic inflammatory condition affecting more than 8 million Americans. There are many variations of this often difficult-to-manage disease, ranging from subtle signs and symptoms to disfiguring plaques and debilitating joint problems. In this activity, an expert clinician affiliated with the National Psoriasis Foundation explains how to recognize the early signs of psoriatic disease, when and how to treat, when to refer to a specialist, pros and cons of the various therapies, and how to provide ongoing care and support for patients at different stages along the disease continuum.
You are eligible to receive a certificate of Advanced Learning in Psoriasis from the National Psoriasis Foundation. Begin by completing this activity, the 1st module of a 2-part activity. You will be automatically directed to the 2nd module. Upon completion of both, you will be issued the certificate.
Format
Interactive video lecture
Learning Objectives
After completing this activity, participants should be better able to:
- Implement screening for cardiovascular disease, metabolic syndrome, and psoriatic arthritis in patients with psoriasis
- Identify side effects of drug classes used in the treatment of psoriatic disease
- Apply long-term management strategies for patients with psoriasis in coordination with a specialist
Target Audience
NPs and PAs
Faculty
Veronica Richardson, MSN, ANP-BC, DCNP
- Nurse Practitioner
- Department of Dermatology
- University of Pennsylvania Health System
- Philadelphia, Pennsylvania
Lawrence Herman, PA-C, MPA
- President
- Palantir Healthcare, LLC
- Boiling Springs, South Carolina
- Past President
- American Academy of Physician Assistants
DETAILS
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.50, which includes 1.50 hour of pharmacology credit
CNE course advisor: Veronica Richardson, MSN, ANP-BC, DCNP, University of Pennsylvania Health System, Philadelphia, Pennsylvania
AAPA Credit Designation
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing MedicalEducation (ACCME) to provide continuing medical education for physicians.
ACCME Credit Designation Statement
The National Psoriasis Foundation designates this live activity for a maximum of 1.50 AMA PRA Category1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s)™ through their reciprocity agreements.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity was developed from a series of programs cosupported by educational grants from AbbVie Inc.; Alcon Vision, LLC; Amgen; Genentech, a member of the Roche Group; Novartis Pharmaceuticals Corporation; Sanofi Genzyme and Regeneron Pharmaceuticals; and Teva Pharmaceuticals.
This activity is supported by an educational grant from AbbVie Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Richardson: advisory board: Ortho Dermatologics, Pfizer.
Mr Herman: consultant/speakers bureau: Novo Nordisk.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.5 hours.
Release date: August 31, 2020
Expiration date: August 30, 2021
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 97120CPCE-7C